Detalhe da pesquisa
1.
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
N Engl J Med
; 384(9): 808-817, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657293
2.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386786
3.
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial.
Am J Gastroenterol
; 118(1): 105-113, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970815
4.
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
J Viral Hepat
; 30(5): 448-454, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740893
5.
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Liver Int
; 43(4): 917-927, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708150
6.
Application and Extension of the Alcohol Recovery Narratives Conceptual Framework.
Qual Health Res
; 33(13): 1203-1217, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683106
7.
The Effect of Covid-19 on Alcohol Use Disorder and the Role of Universal Alcohol Screening in an Inpatient Setting: A Retrospective Cohort Control Study.
Alcohol Alcohol
; 57(2): 203-210, 2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423352
8.
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
Am J Gastroenterol
; 116(11): 2292-2295, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520431
9.
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Liver Int
; 41(6): 1227-1242, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590598
10.
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
Clin Gastroenterol Hepatol
; 18(5): 1170-1178.e6, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606455
11.
Sofosbuvir/velpatasvir for 12â¯weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
J Hepatol
; 71(4): 660-665, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195062
12.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421537
13.
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.
Hepatology
; 67(6): 2113-2126, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473975
14.
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.
Gastroenterology
; 152(5): 1068-1077.e4, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043903
15.
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection.
J Hepatol
; 62(3): 533-40, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450717
16.
The hepatitis C revolution part 1: antiviral treatment options.
Curr Opin Infect Dis
; 28(6): 563-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26524328
17.
The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches.
Curr Opin Infect Dis
; 28(6): 572-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26524329
18.
Chronic hepatitis C - what do the new drugs offer and who should get them first?
Clin Med (Lond)
; 15(2): 197-200, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25824075
19.
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis.
Clin Gastroenterol Hepatol
; 12(10): 1724-30.e5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24530600
20.
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Hepatology
; 57(1): 103-11, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22930399